Skip to main content
Autobound logo

What Stryker's latest 10-Q says: 3 signals

Stryker filed its latest 10-Q with the SEC on Jul 31, 2026. It discusses international growth, litigation material and product liability.

Public (SYK)Medical Equipment Manufacturing10,000+ employeesstryker.comLinkedIn

Filed
Jul 31, 2026
Filings
2
Signals
14

10-Q · latest 10

What Stryker's 10-Q filings say

  1. 10-Q

    Filed · 3 signals

    SEC EDGAR

  2. 10-Q

    Filed · 11 signals

    SEC EDGAR

Showing 10 of 14 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

Stryker earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Raised full-year revenue and EPS guidance, signaling strong business momentum.The company increased its full-year 2025 organic sales growth forecast to 9.8%-10.2% and adjusted EPS to $13.50-$13.60. This upward revision reflects strong demand and operational strength, indicating financial health and budget availability for strategic projects.
Aggressively pursuing M&A, including large deals, as #1 capital priorityCEO Kevin Lobo explicitly stated that acquisitions are the company's top priority for capital allocation, with a strong balance sheet and healthy deal pipeline to support both small and larger deals. This signals active evaluation of external technologies and companies to enhance their portfolio.
Managing ongoing supply chain disruptions in emergency care businessLeadership repeatedly confirmed that the Medical segment, specifically the emergency care business, is being held back by supply chain disruptions. This is a persistent pain point that is impacting their ability to meet demand and achieve higher growth.
Driving toward 100 basis points of operating margin expansion this yearStryker has a firm, company-wide commitment to achieving 100 basis points of adjusted operating margin expansion for the second year in a row. This is being driven by cost improvements, supply chain optimization, and SG&A spend discipline, creating opportunities for solutions that can demonstrate clear ROI.
Planning significant international expansion for Inari business, starting in H2 of next year.Leadership is leveraging Stryker's existing infrastructure to drive a major international push for the recently acquired Inari business. This expansion will require investment in international logistics, regulatory compliance, marketing, and sales operations.
Multiple new product launches are driving growth, including Mako Shoulder and LIFEPAK 35.The company is in the midst of several key product launches, including the LIFEPAK 35 in Europe, the Artix system from Inari, and a full launch of Mako Shoulder planned for H1 next year. These initiatives require spending on marketing, sales training, and supply chain readiness.

Signal API · MCP

Track Stryker with the Signal API

One POST /v1/companies/enrich call with stryker.com returns Stryker 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"stryker.com","signal_types":["sec-10q"],"limit":20}'

Same industry

10-Q at related companies

Questions about Stryker 10-Q

When did Stryker file its latest 10-Q?
Stryker filed its latest 10-Q on Jul 31, 2026. The one before it was filed on May 11, 2026.
What did Stryker disclose in its latest 10-Q?
From the filing dated Jul 31, 2026: Ongoing costs from Rejuvenate, LFIT V40, and Wright legacy hip product recalls
What did Stryker say on its recent earnings calls?
Q3 FY2025: Raised full-year revenue and EPS guidance, signaling strong business momentum. (dated Oct 30, 2025).
Where can I read Stryker's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/310764/000031076426000050/syk-20260630.htm. This page summarizes what the filing says and links to it.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →